Iterative Health, an AI-powered healthcare technology and services company powering the acceleration of clinical research, raised $77 million in a Series C financing round.
The round was co-led by Intrepid Growth Partners and GV (Google Ventures), with participation from new investors EDBI (arm of SG Growth Capital, the investment platform of EDB and Enterprise Singapore) and existing investors Insight Partners and Obvious Ventures.
As part of the financing, Ajay Agrawal, Co-Founder and Partner at Intrepid Growth Partners, will join Iterative Health’s Board of Directors. Anthony Philippakis, General Partner at GV (Google Ventures), will join the board as an observer.
“Intrepid invests in growth-stage companies that harness the power of AI to execute profound system redesigns that vastly enhance productivity across their industry,” said Ajay Agrawal, Co-Founder & Partner of Intrepid Growth Partners.
“Iterative Health is a perfect example of this thesis, having purpose-built its proprietary technology to power a revolutionary clinical trial network that delivers unparalleled speed and scale to the pharmaceutical sector,” added Ajay Agrawal.
With fresh funds, Iterative Health will accelerate expansion into additional therapeutic areas beyond gastroenterology and hepatology, to include deepening its recent entry into cardiology and obesity, as well as continued geographic growth. Iterative Health will continue to broaden partnerships with leading provider organizations, building on existing collaborations with GI Alliance, OneGI, and U.S. Heart & Vascular.
Digital health companies, including AI-powered clinical research technology startups, have secured more than $180 billion in funding to date, according to our recent 2026 Funding Database.
The funding activity is mainly driven by AI-driven digital health startups in 2026. Notable recent funding rounds include:
- Aidoc, a global leader in enterprise-scale clinical AI focused on helping physicians make earlier, safer diagnoses by turning raw patient signals into actionable insight, raised $150 million in a Series E funding round.
- Almanac Health, a provider of an AI-powered point of care evidence-based clinical decision support platform for healthcare providers, raised $10 million in Seed funding.